Skip to content
Medical Health Aged Care, Science

Research reveals gut’s crucial role in lung disease

Centenary Institute 2 mins read

Research led by the Centenary Institute, the University of Technology Sydney and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary disease (COPD), paving the way for new therapeutic treatments.

 

A chronic lung disease characterised by breathing difficulties, COPD is caused by long-term cigarette smoke inhalation or by exposure to airborne pollution or other toxic compounds. It ranks as the third leading cause of death globally.

 

Published in the prestigious science journal Gut, key discoveries from the study include the identification of distinct gut bacteria associated with COPD and the potential effectiveness of faecal microbiota transfer (FMT) as a COPD treatment. The study also demonstrated improved outcomes for COPD patients through nutritional interventions tailored to the microorganisms found in the gut.

 

“The gut hosts the largest and most diverse microbiome in the body that, depending upon its composition, can either trigger or inhibit inflammation, including in the lung,” said senior study author Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation.

 

“We were able to identify specific gut bacteria associated with the development of COPD in our mouse models, confirming the complex interplay between the gastrointestinal microbiome, inflammation and lung disease,” he said.

 

Professor Hansbro added that the study had also demonstrated the potential effectiveness of faecal microbiota transfer (FMT) in the treatment of COPD.

 

“We used FMT to transfer beneficial gut microorganisms between healthy and COPD mice, that helped to reduce lung inflammation and improve breathing. This suggests a potential therapeutic effect of these specific gut microbes in mitigating COPD-related issues," said Professor Hansbro.

 

The lead author of the study, Dr Kurtis Budden, from the Hunter Medical Research Institute highlighted positive outcomes for COPD patients resulting from dietary interventions.

 

"Enhancing the diet of a small select group of human COPD patients through dietary fibre supplementation led to noticeable improvements in disease symptoms. Likewise, providing a high-resistant starch diet to mice with COPD yielded beneficial outcomes. These discoveries point towards a promising direction for dietary modification in the management of COPD,” said Dr Budden.

 

The researchers state that their work opens up exciting new possibilities for microbiome-targeting treatments that could make a real difference in the lives of people dealing with COPD — a disease for which there is currently no cure.

 

[ENDS]

 

Publication:

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

https://gut.bmj.com/content/early/2024/02/08/gutjnl-2023-330521

 


About us:

About the Centenary Institute

The Centenary Institute is a world-leading independent medical research institute, closely affiliated to the University of Sydney and the Royal Prince Alfred Hospital. Our research spans the critical areas of cancer, cardiovascular disease, rare diseases, inflammation, infectious diseases, healthy ageing and biomedical AI. Our strength lies in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients.

 

For more information about the Centenary Institute, visit centenary.org.au

 


Contact details:

For all media and interview enquiries, please contact

Tony Crawshaw, Media and Communications Manager, Centenary Institute on 0402 770 403 or email: t.crawshaw@centenary.org.au

Media

More from this category

  • Disability, Medical Health Aged Care
  • 21/04/2024
  • 17:08
Heart of Health and Disability Conference and Awards

Heart of Health and Disability Unveils Exciting Lineup for Inaugural Conference

GOLD COAST, AUSTRALIA, APRIL 22, 2024—Heart Events is proud to announce the details of its highly anticipated conference and awards, scheduled for July 17th…

  • Contains:
  • Medical Health Aged Care
  • 21/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Ballarat Memory Walk & Jog

What: Dementia Australia’sBallarat Memory Walk & Jog When: Sunday 21 April, from 8am Who: More than 270 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Lake Wendouree, Ballarat For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.